|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 Infectious Disease Division, New York Veterans Administration Hospital and the Department of Medicine, New York University School of Medicine, New York City
Treatment of Candida parapsilosis endocarditis with amphotericin B failed to sterilize blood cultures despite serum levels which were twofold greater than the in vitro minimal inhibitory concentration. Valve tissue excised at operation continued to yield positive cultures despite prolonged immersion in high concentrations of amphotericin. These findings suggest poor penetration of amphotericin B into the vegetations of fungal endocarditis.
Submitted on November 9, 1974
This article has been cited by other articles:
![]() |
A. Vassiloyanakopoulos, M. E. Falagas, M. Allamani, and A. Michalopoulos Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user. J. Med. Microbiol., May 1, 2006; 55(Pt 5): 635 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. El-Hamamsy, N. Durrleman, L.-M. Stevens, L. P. Perrault, and M. Carrier Aspergillus Endocarditis After Cardiac Surgery Ann. Thorac. Surg., July 1, 2005; 80(1): 359 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Marchetti, J. M. Entenza, D. Sanglard, J. Bille, M. P. Glauser, and P. Moreillon Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans Antimicrob. Agents Chemother., November 1, 2000; 44(11): 2932 - 2938. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |